Vyne Therapeutics Inc. (VYNE) SEC Filings — 2024
13 SEC filings for Vyne Therapeutics Inc. (VYNE) in 2024.
Filings
- VYNE Therapeutics Files 8-K — 8-K · Dec 23, 2024
- VYNE Therapeutics Appoints New CEO, Files 8-K — 8-K · Dec 12, 2024
- Vyne Therapeutics Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- VYNE Therapeutics Files Definitive Proxy Statement — DEF 14A · Nov 12, 2024
- VYNE Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 7, 2024
- VYNE Therapeutics Files 8-K — 8-K · Sep 12, 2024
- VYNE Therapeutics Files Q2 2024 10-Q Report — 10-Q · Aug 14, 2024
- VYNE Therapeutics Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- VYNE Therapeutics Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 1, 2024
- VYNE Therapeutics Files 8-K on Financial Condition — 8-K · Feb 29, 2024
- Vyne Therapeutics Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Soleus Capital Amends VYNE Therapeutics Stake as of Dec 31, 2023 — SC 13G/A · Feb 2, 2024
- VYNE Therapeutics Reports Officer/Director Changes, Comp Arrangements — 8-K · Jan 3, 2024